Actively Recruiting

Age: 1Day - 28Days
All Genders
ID07356583

Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11

Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2026-03-27

1600

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

F

Fondazione IRCCS Policlinico San Matteo di Pavia

Lead Sponsor

A

ASST Fatebenefratelli Sacco

Collaborating Sponsor

AI-Summary

What this Trial Is About

Enteroviruses are a group of RNA viruses including Coxsackievirus, Echovirus, Poliovirus, and Rhinovirus types. They commonly cause mild illnesses in infants and children but can sometimes lead to serious diseases like liver failure, neurological damage, and heart problems. Recently, severe cases of neonatal Echovirus 11 infection with high fatality rates were reported in several European countries, highlighting the need for better understanding and surveillance of these infections. This research aims to develop and test methods for tracking enterovirus infections in newborns, focusing on Echovirus 11. Activities include screening newborns in intensive care for enterovirus infections, using advanced genetic sequencing to analyze virus strains, and studying viral features that may influence disease severity. The study runs from February 2026 to February 2027 and will collect data to improve detection and understanding of these infections. Participants include neonates admitted to intensive care units whose samples will be tested for enteroviruses. Researchers will estimate infection rates and perform detailed genetic and epidemiological analyses. The study seeks to identify viral variations and host factors linked to severe disease. Sample collection, genomic sequencing, and clinical data analysis are key components. The goal is to enhance knowledge for better diagnosis and management of neonatal enterovirus infections.

CONDITIONS

Brief Title

Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11

Who Can Participate

Age: 1Day - 28Days
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Samples from consecutive neonates admitted to neonatal intensive care unit
Not Eligible

You will not qualify if you...

  • Insufficient residual samples (volume less than 1 mL of nasal swab) will be excluded from the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Sample Collection

Duration - February 2026 to February 2027

Samples are collected from neonates admitted to the neonatal intensive care unit for virological and genomic analysis.

Trial Site Locations

Total: 1 location

1

Fondazione IRCCS Policlinico San Matteo

Pavia, Lombardy, Italy, 27100

Actively Recruiting

Loading map...

Research Team

A

Antonio Piralla

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase III, Open Label, Randomized, Controlled Study of VBI...

Septic Shock

Actively Recruiting

6 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here